Results 171 to 180 of about 19,867 (255)

Oncolytic viruses and neoantigen vaccines: opportunities and challenges in priming antitumour immunity. [PDF]

Lancet Reg Health Eur
Mansinho A, Albuquerque J, Calvo E.
europepmc   +1 more source

Reprogramming the immune orchestra for glioblastoma: oncolytic viruses and the B-cell connection. [PDF]

Cell Mol Immunol
Dieli C, Di Simone M, Dieli F, Meraviglia S.   +3 more
europepmc   +1 more source

Engineering antibody-armed oncolytic viruses: design strategies, synergistic mechanisms, and clinical translation. [PDF]

Front Immunol
Kang X, Yang X, Wu H, Tong X, Wang S.
europepmc   +1 more source

Issue Information

Microbiota Medicine Research, Volume 1, Issue 2, Page i-iv, June 2026.
No abstract is available for this article.
wiley   +1 more source

Cancer frenemy pathways: Inducing immunogenic cell death by exploiting apoptosis-interferon antagonism with oncolytic viruses. [PDF]

Mol Ther Oncol
Bozhdansky V, Bacharach E, Ehrlich M.
europepmc   +1 more source

Recent Progress in Engineered Oncolytic Viruses: A Thematic Review

This review examines recent research in engineered oncolytic viruses and applies a thematic analysis to identify trends in the field. The major themes identified are tumor microenvironment remodeling, enhancing virus efficiency, treating slow-growing ...
Manjila, Nihal
core  

Oncolytic Viruses: Promising Future in Cancer Treatment. [PDF]

Adv Pharm Bull
Nazim AN, Subbaram K, Faiz R, Ali S.
europepmc   +1 more source

Publication Only

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Oncolytic viruses: Revolutionising the fight against tumours. [PDF]

Clin Transl Med
Zhao Z, Shen Y, Liang T.
europepmc   +1 more source

A Comprehensive Review of Modern Cancer Therapies Utilizing Oncolytic Viruses. [PDF]

Cells
Sułek M, Szuster-Ciesielska A.
europepmc   +1 more source